Cost considerations regarding the prospective surveillance model for breast cancer survivors

Cancer

Volumn 118, Issue SUPPL.8, 2012, Pages 2325-2330

  Cheville, Andrea L ^a   Nyman, John A ^b   Pruthi, Sandhya ^a   Basford, Jeffrey R ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Breast cancer; Cost effectiveness; Physical impairment; Screening; Survivorship

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER SCREENING; CANCER SURVIVAL; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; MODEL; PRIORITY JOURNAL; PROSPECTIVE SURVEILLANCE MODEL; PSYCHOLOGICAL WELL BEING; REIMBURSEMENT; REVIEW;

ADULT; AGED; AMERICAN CANCER SOCIETY; BREAST NEOPLASMS; CONGRESSES AS TOPIC; COST-BENEFIT ANALYSIS; DISABILITY EVALUATION; FEMALE; HEALTH CARE COSTS; HUMANS; LONGITUDINAL STUDIES; LYMPHEDEMA; MIDDLE AGED; MOBILITY LIMITATION; MUSCULOSKELETAL DISEASES; PHYSICAL THERAPY MODALITIES; PROSPECTIVE STUDIES; SURVIVORS; UNITED STATES;

EID: 84859627901     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27473     Document Type: Review

References (24)

1. Stout NL, Andrews K, Binkley JM, Schmitz KH, Smith RA. Prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118(suppl 8):2191-2200.
2. Lehmann JF, DeLisa JA, Warren CG, deLateur BJ, Bryant PL, Nicholson CG. Cancer rehabilitation: assessment of need, development, and evaluation of a model of care. Arch Phys Med Rehabil. 1978;59:410-419. (Pubitemid 9025186)
3. Guadagnoli E, Mor V. Daily living needs of cancer outpatients. J Commun Health. 1991;16:37-47.
4. Cheville AL, Troxel AB, Basford JR, Kornblith AB. Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol. 2008;26:2621-2629.
5. Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood). 2008;27:759-769. (Pubitemid 351770245)
6. American Cancer Society. Available from: http://www.cancer.org/ Cancer/BreastCancer/OverviewGuide/breast-cancer-overview-keystatistics. Accessed August 22, 2011.
7. Gartner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302:1985-1992.
8. Rietman JS, Geertzen JH, Hoekstra HJ, et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol. 2006;32:148-152. (Pubitemid 43257114)
9. Bower JE, Ganz PA, Desmond KA, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006;106:751-758. (Pubitemid 43238440)
10. Cheville AL, Beck LA, Petersen TL, Marks RS, Gamble GL. The detection and treatment of cancer-related functional problems in an outpatient setting. Support Care Cancer. 2009;17:61-67.
11. McNeely ML, Campbell K, Ospina M, et al. Exercise interventions for upper-limb dysfunction due to breast cancer treatment [serial online]. Cochrane Database Syst Rev. 2010;(6):CD005211.
12. Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial [serial online]. BMJ. 2010;340:b5396.
13. Fisher ES. Medical care - is more always better? N Engl J Med. 2003;349:1665-1667. (Pubitemid 37288573)
14. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
15. Goldberg JI, Wiechmann LI, Riedel ER, Morrow M, Van Zee KJ. Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema. Ann Surg Oncol. 2010;17:3278-3286.
16. McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26:5213-5219.
17. Springer BA, Levy E, McGarvey C, et al. Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer. Breast Cancer Res Treat. 2010;120:135-147.
18. Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112:2809-2819. (Pubitemid 351969228)
19. Luft HS. Economic incentives to promote innovation in healthcare delivery. Clin Orthop Relat Res. 2009;467:2497-2505.
20. Rockson SG. Lymphedema. Am J Med. 2001;110:288-295. (Pubitemid 32187290)
21. Cheville AL, McGarvey CL, Petrek JA, Russo SA, Taylor ME, Thiadens SR. Lymphedema management. Semin Radiat Oncol. 2003;13:290-301. (Pubitemid 36962651)
22. Shih YC, Xu Y, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27:2007- 2014.
23. Bosco JL, Silliman RA, Thwin SS, et al. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol. 2010;63:64-74.
24. Doshi JA, Glick HA, Polsky D. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials. Value Health. 2006;9:334-340. (Pubitemid 44337786)